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Summary
A review of the methods currently used for the extraction and analysis of basic drugs 
from biological matrices has been carried out. The aims of this project were to 
develop a method for the extraction of basic drugs from whole blood using solid- 
phase extraction (SPE) and gas chromatography with flame ionisation detection (GC- 
FID).
A comparative evaluation was made of three experimental mixed-mode SPE columns 
(HCX-2, HCX-3 and HCX-4) to three mixed-mode SPE columns currently in use 
(HCX, ENV+ and Bond Elut Certify). HCX-2, HCX-3 and HCX-4 columns 
consistently gave better or comparable drug recoveries when compared to the other 
columns.
Two extraction methods were developed, which were able to produce recoveries of 
greater than 60% for each of the nine basic drugs using the experimental columns. 
Both methods involved a sample pretreatment step, including sonication (to break up 
the red blood cells and release the drugs) and dilution with a buffer (to reduce the 
viscosity of the blood and prevent blockage of the column). The methods differed in 
the pH of the 0.1M phosphate buffer used. Method A involved a buffer pH of 6.0, 
while Method B used a buffer pH of 7.4, both produced clean extracts, with no 
coeluting material.
For GC-FID analysis, an HP-1, fused-silica wide-bore capillary column (30m x
0.53mm i.d., film thickness 0.88pm) was chosen with a Helium carrier gas flow rate 
of 13mL/min. The temperature program used, was that stated by Chen et al11. The 
extraction methods separated the drugs into two fractions, Fraction A included all the
weakly basic drugs and Fraction B, the remaining basic drugs. Prazepam was used as 
the internal standard.
Linear calibration curves were produced for each of the nine basic drugs over a range 
of ng/mL and pg/mL levels and from a total of lmL of blood, the limit of detection 
for the drugs ranged from 7.5 to 16 ng/mL. Due to time restrictions, only Method B 
in conjunction with an HCX-3, SPE column were used to demonstrate a linear 
response, for quantitative analysis. The procedure produced linear calibration curves 
for each of the drugs with correlation coefficients ranging from 0.99937 to 0.99985.
In conclusion, the optimum method established in this study, for the extraction and 
analysis of basic drugs from whole blood, involved the use of a phosphate buffer of 
pH 6.0 or 7.4, along with the extraction steps cited in Chen et al27, followed by GC - 
FID as the end-step analysis.
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Chapter One: Introduction
Drug abuse in the West of Scotland, as in society in general, has increased 
dramatically over the past decade (Figurel.l). As a result of this, the number of 
deaths caused directly from drug use, e.g. overdose1 or indirectly, e.g. road traffic 
accidents2 , has also increased. Drugs impair psychomotor skills and cause
hazardous driving3.
As a consequence of the increase in demand for drug identification, it is the role of 
the Forensic Toxicologist to develop a method which is both rapid and reproducible 
for the analysis of biological matrices.
Systematic Toxicological Analysis (STA) is defined as the logical chemical - 
analytical search for an unknown substance of toxicological relevance3. The first 
step is to establish whether the compound can be identified (screening) and secondly, 
to identify the compound (identification and confirmation).
Biological samples have to undergo a series of sample pre-treatment steps, to remove 
any endogenous materials and to increase the drug concentration, before being 
introduced onto a chromatographic column.
Technological advances in chromatographic analytical equipment have afforded the 
scientist with the means of separating a complex mixture of analytes and confirming 
their presence. However, sample preparation techniques have not improved as 
quickly and this remains the limiting factor for a totally automated analysis and is the 
source of greatest variability4.
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Isolation of drugs from whole blood was until recently, time consuming and wasteful 
of sample due to inefficient preparation and extraction techniques. The use of Solid- 
Phase Extraction (SPE) as an alternative to Liquid-Liquid Extraction (LLE) has 
demonstrated the advantages of this technology in producing better extraction results. 
This is of great importance as whole blood is the most widely available sample for 
forensic toxicological analysis.
LLE continues to be the method of choice in most Forensic Toxicology laboratories, 
despite the obvious advantages of SPE. Scheurer and Moore4, gave one explanation 
for this being that, Forensic Labs are in the unique position where their results are 
subject to severe scrutiny in courts. In the past SPE had problems with 
reproducibility, due to lack of quality control on the packing materials used.
However, with the advent of mixed-mode SPE columns, the problems of not being 
able to extract a wide range of drugs with varying physical and chemical properties 
became a thing of the past as did the problems with reproducibility.
The majority of SPE methods reported, involve the selective extraction of individual 
drugs or groups of similar drugs. Of those methods which screened a large group of 
drugs5,6,7, most analysed samples other than blood and none of them included all of 
the drugs included in this research project.
The aims of this study were to:
(1) Compare and evaluate the extraction efficiencies of three experimental mixed­
mode SPE columns using whole blood,
(2) Compare the three experimental mixed-mode SPE columns to mixed-mode
An Evaluation o f Mixed-Mode Solid-Phase Extraction Columns for the Recovery of Basic Drugs from Whole Blood
Chapter One Introduction page4
columns currently in use, and
(3) Develop a validated method for screening basic drugs in whole blood samples 
using SPE and GC-FID.
1.1 Drug Abuse: An Overview
The abuse of drugs both legal and illegal has increased alarmingly throughout the 
United Kingdom. Tobacco smoking is thought to contribute to 100,000 premature 
deaths in the UK every year and alcohol abuse is prevalent in a society where 90% of 
the adult population drink.8
Although relevant data relating to the prevalence of drug usage in the United 
Kingdom is not readily available, it can be assumed to be on the increase, due to the 
increase in drug related deaths1 and the number of notified drug addicts1. From 1992 
to 1993 their was a 13% increase in the number of drug addicts who were notified to 
the Home Office, 40% of which were newly registered. This increasing trend has 
been constant over the past few years. The number of deaths attributed to drug 
misuse of notified drug addicts was reported to be 83 in 1981 and this figure had 
increased to 206 in 1991. Of those, opiates and methadone overdose, accounted for 
the vast majority of deaths1.
Drug misuse databases reported that 17,800 people from across England started 
treatment between October 1st 1992 and March 31st 1993.9 Heroin accounted for 
approximately 50% of the main reported drug problem, methadone(15%), 
amphetamines(ll%), cannabis(7%), benzodiazepines(4%) and cocaine(3%).
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Looking specifically at the Scottish Drug Scene10, only 2 deaths were recorded in 
1984 from the misuse of heroin. However, for the Strathclyde region alone, this had 
increased to 101 drug related deaths in 1993 and 145 in 1995. Deaths occurring in 
the late 1980's were attributed to Heroin abuse, but at the start of the 1990's the abuse 
of benzodiazepines featured much more11.
The nine drugs chosen for this project, are representative of the different classes of 
drugs which are more commonly abused in the UK. Table 1 summarises these drugs 
along with their drug type and effects12.
Table 1: Drugs anc their effects.
Drug Name Drug Type Effects
Amitriptyline Tricyclic Antidepressant Sedative effects, elevates mood, 
increases physical activity and 
appetite.
Cocaine
Methamphetamine
Local Anaesthetic 
Central Stimulant
Central Nervous System 
stimulants: increases alertness 
and diminishes fatigue.
Codeine
Dihydrocodeine
Methadone
Propoxyphene
Narcotic Analgesic 
Narcotic Analgesic 
Narcotic Analgesic 
Narcotic Analgesic
Reduces sensitivity and 
emotional reaction to pain, 
discomfort and anxiety.
Diazepam
Desmethyldiazepam
Tranquilliser
Tranquilliser
Central Nervous System 
Depressants: promote relaxation, 
impair the efficiency of mental 
and physical functioning.
1.2 Forensic Toxicology
Toxicology is the study of poisons and the term 'poison' is used to describe any 
substance which has a harmful effect on a living system. For the purposes of this
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project, we are looking specifically at the toxicology of drugs, primarily, illegal 
drugs.
It is of great importance to know whether someone died due to the effects of a drug, 
in the case of suicide, homicide (very rare), or accidental poisoning.
The toxicity of a drug does not only depend on its toxic properties but also on the 
dose administered. However, there is no direct relationship between the dose and the 
effects that it elicits. Many factors contribute to the effects of a drug from one 
individual to another, e.g. tolerance and what would constitute a fatal dose to one 
person may have little or no effect on another.
A summary of the therapeutic, suggested toxic and fatal levels of the nine drugs used 
in this study (fig/mL) are presented in Table 2.
Table 2: Therapeutic, Toxic and Fatal Levels of Drugs(|ig/mL)13.
Drug Therapeutic Toxic Fatal Half-Life(Hrs)
Amitriptyline 0.05 - 0.2 0.05 - 0.17 0.55 - 3.3 8 - 51
Cocaine 0.05 - 0.3 0.9 1.0-20 0.7 -1 .5
Codeine 0.01 - 0.250 0.3 - 0.5 > 1.6 2 - 4
Diazepam 0.125-0.75 1.5-5.0 20 -100
Dihydrocodeine 0.03 - 0.25 1.0 2.0 4
Methadone 0.1-0.75 1.0-2.0 >4.0 10-55
Methamphetamine 0.01 - 0.075 0.2- 1.0 10-40 9
Propoxyphene 0.1-0.75 1.0 > 2 8 - 2 4
Desmethyldiazepam 0.17-1.84 25 - 200
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Amphetamines are the most popular illicit stimulant, second only to cannabis in the 
overall league table of illicit use9. Methadone is often used in the treatment of opiate 
addiction. Propoxyphene is a synthetic analgesic agent and misuse induces toxic 
overdose reactions involved in accidental and suicidal poisonings14. Amitriptyline 
along with other tricyclic antidepressants are among the most commonly prescribed 
drugs for the treatment of endogenous depression15.
Benzodiazepines are the most commonly prescribed drug in the world, used as 
antianxietics, hypnotics and antiepileptics. They are also the most frequently 
encountered drug in Forensic and Clinical Toxicology16. Codeine and dihydrocodeine 
are two of the markers found after opiate abuse. Cocaine and heroin are reported to 
be the most commonly found drug combination with the exception of alcohol17.
1.3 Systematic Toxicological Analysis
The main purpose of Systematic Toxicological Analysis (STA), is to detect and 
identify unknown substances in a given matrix18.
Drug screening in STA is an extremely important preliminary step in the analysis of 
biological specimens and involves two main steps;
1. Sample Preparation (clean-up and extraction) and
2. actual analysis for determination and confirmation.
Sample pretreatment produces a cleaner sample and leads to greater selectivity and 
precision, by eliminating any matrix effects which may interfere with the analysis.
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The extraction is optimised through adjustment of the pH, ionic strength and sample 
concentration.
Traditionally, liquid-liquid extraction (LLE) techniques were used to separate 
analytes from biological matrices. However, they were found to be tedious, time 
consuming and were not always sufficiently reproducible.
Solid phase extraction (SPE) emerged in the mid 1970's19 as a simpler alternative to 
LLE and has since proved to be an extremely effective means of extracting drugs 
from biological matrices with several distinct advantages over LLE18. These include 
reduced solvent usage, cleaner extracts, no emulsion formation and considerable 
reduction in analysis times.
Several analytical techniques have been used for the screening of drugs, these 
include, Thin Layer Chromatography (TLC), Immunoassay, High Performance 
Liquid Chromatography (HPLC) and Gas Liquid Chromatography (GLC).
The ideal analytical method, should be specific, statistically defined (accuracy, 
precision and sensitivity), and routinely reliable20.
In forensic Toxicology, capillary GC and capillary GC/MS are often the preferred 
methods for analyte confirmation and quantification21. A number of authors have 
reported the benefits of using GC, for drug screening22, and when used in conjunction 
with Retention Indices23. Chen et al24 reported GC to have good separation 
efficiency, high sensitivity, inertness and especially valuable for drug screening.
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For the purposes of this project, Gas Liquid Chromatography connected to a Flame 
Ionisation Detector was used in conjunction with retention indices (RI) for the 
identification of basic drugs.
1.4 Solid-Phase Extraction
1.4.1 Introduction
Solid-Phase Extraction (SPE) was introduced as a simpler alternative to Liquid- 
Liquid Extraction (LLE) in the mid 1970's, to try and combat the problems 
encountered with this method18, i.e.,
1. Phase emulsion
2. Large solvent volumes
3. Impure and wet extracts
4. Non-quantitative and irreproducible extractions
5. Time consuming
6. High costs
7. Several sample handling steps.
The first bonded phases used were of hydrophobic character, e.g. C l8 and XAD 
resins25. These single phase columns showed great promise for the analysis of 
biological samples, but problems occured with co-extraction of endogeneous 
materials.
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Ion-exchange columns were introduced in the 1980's and successfully extracted a 
wide range of compounds of differing chemistries, of both basic and acidic character. 
Improvements with sample clean-up and recovery were also reported, however 
extraction of neutral compounds still remained a problem.
Mixed-mode bonded silicas, consisting of both hydrophobic and ion-exchange 
properties in one single column e.g., Clean Screen®, first introduced in 198625, 
enabled the extraction of a range of drugs, including neutral compounds7.
SPE is a powerful pretreatment technique for the clinical and toxicological drug 
analysis of biological samples26 and over the years has become more and more 
acceptable in Forensic Toxicological laboratories18,27, having very distinct 
advantages over LLE. These advantages include:
1. High selectivity
2. Cleaner extracts
3. No emulsion formation
4. Better reproducibility
5. Reduced solvent usage
6. Higher throughput due to automation7,21,24
7. Less contamination of GC system.
1.4.2 Principles of Solid Phase Extraction
The extraction procedure in SPE, involves the interaction between a solid and a 
liquid phase, and is a physical extraction process, similar to Liquid
An Evaluation of Mixed-Mode Solid-Phase Extraction Columns for the Recovery of Basic Drugs from Whole Blood
Chapter One Introduction pagell
Chromatography28. However, the aims of SPE are to isolate and then concentrate the 
compounds of interest, while Liquid Chromatography aims to separate the 
compounds, with good peak shape and height, and short retention times28.
There are many different sorbent materials available, e.g diatomaceous earth, silica 
and bonded silica gels. Bonded silicas are the most frequently used sorbent as they 
can be modified with different functional groups to produce highly stable non­
swelling stationary phases which allow for a wider range of extraction capabilities. 
Secondary interactions also take place where the isolate molecules interact with the 
silica substrate as opposed to the functional group28.
The extractions can be separated into three types, depending on the functional groups 
bonded to the silica; non-polar, polar and ion-exchange.
Non-Polar
Non-polar interactions result between the carbon-hydrogen bonds of the sorbent and 
of the isolate and are caused by "Van der Waals" or "dispersion forces". The majority 
of organic molecules have some non-polar character and so are retained on the 
surface of sorbents containing non-polar functional groups.
Octadecyl silane (C l8) is the most frequently used non-polar sorbent and is non- 
selective, resulting in the retention of a variety of structurally unrelated isolates. 
Retention of isolates onto non-polar sorbents is facilitated by the use of polar 
solvents, while elution requires a solvent of sufficient non-polar character to disrupt 
the non-polar interactions between the isolate and the sorbent.
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Polar
Groups with polar character include, hydroxyls, amines, aromatic rings and hetero­
atoms, e.g. oxygen and nitrogen. These are retained on sorbents containing polar 
functional groups due to hydrogen bonding, dipole/dipole, induced dipole/dipole, pi- 
pi and other polar interactions resulting from the uneven distribution of electrons 
between individual atoms in the functional group.
Secondary interactions due to the polar character of the silica substrate are present in 
all bonded silicas. Retention of isolates onto polar sorbents is facilitated by the use 
of non-polar solvents, while elution requires a polar solvent of sufficiently high ionic 
strength to disrupt the polar interactions between the isolate and the sorbent.
Ionic
Ion-exchange occurs between groups present on the isolate and the sorbent with 
opposite charges. There are two classes of these groups: cationic (positively 
charged), e.g. primary, secondary, tertiary, and quartemary amines, and anionic 
(negatively charged), e.g. carboxylic and sulphonic acids. Depending on the pH of 
the solvent environment, these molecules can exhibit cationic or anionic character. 
Two criteria have to be met before the retention of an isolate by an ion-exchange 
mechanism can take place;
1. the pH of the system must be such that both isolate and sorbent are 
charged, and
2. the system must not contain high concentrations of strongly competing 
ionic species of the same charge as the isolate.
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The pKa is defined as the pH at which half of the molecules in solution are charged 
and the other half are not. Increasing the pH to a value above the pKa of anionic 
molecules, increases the number of charged anionic groups and decreasing the pH, 
decreases the number of charged molecules. The opposite is found with cationic 
groups.
In order to achieve retention of ionic groups, both the sorbent and the isolate have to 
be charged, i.e. at a pH below the pKa of the cation and at a pH above the pKa of the 
anion. A pH of at least two pH units below the pKa of the cation and two pH units 
above the pKa of the anion is required for approximately 99% of the groups to be 
charged.
Other factors which are important in ion-exchange are ionic strength and selectivity. 
Ionic strength is a measure of the total ionic concentration of ionic species present 
within the solvent/matrix environment. Ion-exchange is a competitive process and so 
low ionic strength encourages retention of the isolates while high ionic strength 
disrupts it. Selectivity describes the preference shown by ion-exchange sorbents for 
certain types of ionic groups over others. Ionic secondary interactions also occur due 
to unbonded silanols on the silica substrate.
Retention of an isolate onto a sorbent matrix occurs through the interaction of a 
combination of the three extraction mechanisms, i.e. non-polar, polar and ion- 
exchange, these interactions are dependent on the sample matrix and solvent 
environments.
Table 3, contains information on the non-polar and polar phases of the three 
experimental mixed-mode columns and the standard HCX column.
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Table 3: Information on Column Packing Materials
Product Part# Compostion Comment
HCX 902 LC C8 (UC) + PRS Standard mixed sorbent product, 
made with low carbon loading C8 
(non-end capped) + propyl- 
sulphonic acid strong cation 
exchanger.
HCX-2 912 C12 (UC) + PRS Non-end capped C12 + propyl- 
sulphonic acid strong cation 
exchanger.
HCX-3 913 C18 (UC) + PRS Non-end capped C l8 + propyl- 
sulphonic acid strong cation 
exchanger.
HCX-4 914 C8 (UC) + PRS Standard C8 (non-end capped) + 
propylsulphonic acid strong cation 
exchanger.
HCX contains low carbon loading C8 non-end capped sorbent which would result in 
the least non-polar retention characteristics of the four columns, followed by HCX-4, 
HCX-2 and then HCX-3 having increasingly more non-polar character.
Each of the columns contains a 4:1 mixure of the non-polar sorbent to PRS.
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1.4.3 Procedural Steps in Solid Phase Extraction
In its simplest form, a solid phase extraction procedure consists of five steps: column 
preconditioning, sample application, column wash, column drying and drug elution.
1. Column Preconditioning
Before applying a pretreated sample to an extraction column, the active sites on the 
column have to be activated with a suitable solvent. Bonded silica sorbents are dried 
and packed and so are not available to interact with the analytes. Application of the 
sample before solvation would result in low and irreproducible recoveries.
2. Sample Application
Once the column is solvated, the sample is applied onto the column under a light 
vacuum. The flow rate of the sample through the column is very important, as a low 
flow rate allows the necessary time for the maximum amount of drugs to interact 
with the active sites on the column. Normally this would be 1.5mL/min.
3. Column Wash
The wash step allows the removal of any endogenous components that were retained 
by the active sites. Water or an appropriate solvent is used to selectively remove any 
material which could interfere with the analysis. Selection of a solvent which will 
not remove any of the relevant drugs can be difficult and so a compromise must be 
reached between acceptable recoveries and removal of interfering compounds.
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4. Column Drying
This is an extremely important step, especially when Gas Chromatography is used for 
the final analysis, as any residual water may cause damage to the GC column. The 
water may be removed by applying a vacuum to the column or by the addition of a 
solvent, e.g. Methanol27.
5. Elution of Relevant Drugs
In order to elute the drugs for analysis, a suitable solvent is chosen which will extract 
only the drugs of interest and leave any remaining matrix interferents on the column. 
The solvent should also be strong enough to displace all of the drugs into a small 
eluent volume. Large eluent volumes have the disadvantage of diluting the extract, 
extracting more impurities and increasing the extraction time. An evaporation step is 
usually included at this stage to concentrate the drugs, however care must be taken to 
prevent the loss of more volatile drugs, e.g. amphetamines.
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Chapter Two - Literature Review
2.1 Introduction
Drug screening in Systematic Toxicological Analysis (STA) is an important 
preliminary step in the analysis of biological materials. In order to analyse a sample, 
two steps are required: 1 . clean-up and extraction, and 2 . detection.
Developments in the analysis of biological samples have resulted in, more efficient 
drug recoveries due to better clean-up steps, new extraction techniques and advances 
in chromatographic separation. These improvements have permitted methods which 
have greater reproducibility, and are quick and easy to use.
A review of the recent literature has revealed the increasing use of Solid-Phase 
extraction (SPE) as an alternative to Liquid-Liquid extraction (LLE) and there has 
been extensive research using both techniques for the extraction of drugs from 
urine29and plasma30 as well as unconventional tissues, e.g. meconium31, hair17 and 
vitreous humor32.
SPE was primarily used for the analysis of urine and plasma samples, as whole blood 
tended to block the columns and cause reduced extraction efficiencies. This was 
resolved by sonication of the blood to fragment the red blood cells33, then diluting the 
sample with an appropriate buffer34, to ease the flow through the column. This is of 
great importance, as whole blood is the most widely available sample for forensic 
toxicological analysis and postmortem blood samples are very rarely able to be 
separated due to degredation (putrefaction).
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Previous work carried out using SPE of whole blood, has concentrated on the 
extraction of individual or closely related groups of drugs35’36’37’38. As a consequence 
of this, the methods which are available are very specific and are inappropriate for 
the simultaneous screening of various classes of drugs.
2.2 Liquid-Liquid Extraction (LLE)
LLE has been used successfully as a means of extracting different drugs from 
biological specimens for many years, and is still the preferred method in many 
laboratories.
De Gier and 't Hart39 reported recoveries of 97 ± 8 % for Diazepam and 100 ±12%  
for Desmethyldiazepam extracted from plasma into a toluene - heptane mixture at 
pH9. Prazepam was used as the Internal Standard (IS). Before analysis of the extract, 
derivatisation of N-desmethyldiazepam was carried out to give the N-butyl derivative 
which along with Diazepam was detected using Electron-Capture Gas 
Chromatography (EC-GC).
Al-Hadidi and Oliver40 utilised LLE in order to study the stability of Temazepam in 
Blood, while Laakkonen and Heiskanen41 developed a procedure for screening serum 
samples for benzodiazepines using LLE in conjunction with Gas Chromatography 
connected to a Nitrogen-Phosphorus Detector (GC-NPD) and with High Performance 
Liquid Chromatography (HPLC).
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LLE has also found applications in screening for a large number of unrelated 
drugs42’43’44’45 using a variety of detection techniques, including, Immunoassay14’46’47, 
GC-NPD48 and High Performance Liquid Chromatography using a Diode Array 
Detector (HPLC-DAD)49.
Hughes and Osselton15 compared nine Liquid-Liquid and two Solid-Phase extraction 
procedures which were evaluated on the basis of sample cleanliness, extraction 
efficiency and reproducibilty. HPLC was used for the identification and 
quantification of Tricyclic Antidepressants from whole blood samples. LLE 
extraction methods were reported as being the preferred method, as they were 
simpler, less time consuming and more suitable for forensic casework. Solid-Phase 
extractions were performed on Analytichem Bond-Elut™ cyanopropyl (CN) 
extraction cartridges (lmL) and involved no sample pretreatment prior to extraction.
LLE involves the use of large solvent volumes, which are expensive and require 
complex and lengthy sample handling steps. SPE does not suffer from either of these 
problems and with the advent of better sample preparation techniques, the extraction 
of drugs from whole blood using SPE has been made possible4.
2.3 Solid-Phase Extraction
2.3.1 Introduction
The first materials to be used for the Solid-Phase extraction of urine samples were 
first reported in 1970 with the introduction of Amberlite® XAD-2 resins (cross- 
linked polystyrene - divinyl benzene by Rohm and Haas; Philadelphia, PA)18. Use of
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these resins included screening for drugs of abuse in urine50 and more recently, the 
extraction of cocaine and benzoylecgonine from postmortem blood19.
The need for large volumes of resin, multiple stepped analysis and the time required 
to complete the extraction made these phases expensive and difficult to use. Sep-Pak 
C18 cartridges were introduced in 1978 by Waters Associates (Milford, MA)18. 
These smaller columns decreased the analysis time and costs associated with drug 
analysis and proved useful for the extraction of tricyclic antidepressants from 
vitreous humor31 and benzodiazepines from urine16. To obtain similar recoveries 
from plasma, a deproteinization step was required.
New methods reported for SPE, outnumber those reported for LLE, demonstrating 
the shift from LLE to SPE in both clinical and forensic toxicological laboratories. 
One other type of solid-phase used, is Extrelut (Merck, France) which has found 
applications in the analysis of propoxyphene and related compounds51 and 
Benzodiazepines52 in blood. Extrelut is available as a prepacked column or in 
granular form.
Several single-mode columns have been introduced for the analysis of urine and 
plasma samples including Bond Elut C / 3*54, Bond Elut C^ 53*55 and Detectabuse 
GC/MS grade columns56. These columns contain non-polar sorbent materials (C2, 
C18) and methods have been reported for analysis of individual drugs and groups of 
structurally related drugs. Problems with low recoveries arose when screening 
samples for a wide range of drugs using a single-mode column. Lillsunde and Korte5 
used a Chem Elut™ (Analytichem International) column to extract 300 drugs from 
urine and reported recoveries ranging from 10 to 90%.
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Cosbey et al51, investigated the use of a 2-stage process involving two cartridges with 
different phases, 1. Supelclean-ENVIcarb (hydrophobic extraction using non-porous 
carbon) and 2. Bondelut PRS cartridge (ionic extraction on a strong cation 
exchanger), to extract basic drugs from whole blood. Recoveries for the drugs 
studied were high, e.g. 89.9% for Quinine. However, the problems encountered with 
single-mode columns remained with this 2 stage method as the second extraction can 
only separate the drugs extracted from the first column.
Logan et al6, reported the use of a Bond Elut strong cation exchange (SCX) column 
(Analytichem), which contains silica particles with alkyl-bonded benzene- 
sulphonylpropyl, which combined both cation exchange and non-polar properties. 
This column was found to extract efficiently, over 100 basic drugs from urine, as 
well as certain drugs which proved difficult with LLE, e.g. morphine, 
benzoylecgonine, temazepam and oxazepam.
2.3.2 Mixed-Mode SPE Columns
Improvements continued with the introduction of mixed-mode SPE columns: Clean 
Screen™ DAU (Worldwide Monitoring Corporation: Horsham, PA), Bond Elut 
Certify™ (Varian Sample Preparation Products: Harbor City, CA) and narc2™spe 
(J.T. Baker: Phillipsburg, PA). These SPE columns have provided the analyst with 
the means of selectively extracting a broad range of drugs from various biological 
matrices. The sorbent consists of both hydrophobic and cation exchange groups.
Clean Screen™ DAU columns have been used for the extraction of cocaine and its 
metabolites17’38 from a variety of matrices and for screening plasma and urine for
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drugs of different physicochemical properties24. Bond Elut Certify™ has been used 
for the analysis of single or groups of related drugs in plasma30, whole blood31’58 and 
urine29’59 samples.
The advantages of using a mixed-mode column as opposed to a single-mode column 
include, cleaner extracts and the ability to extract a wider range of drugs with 
different physicochemical properties. As these mixed-mode sorbents are contained 
in just one column, they have the added advantage of requiring less extraction steps 
and so are easier to use, as well as being more cost effective than the dual column 
procedure.
Chen et al26, investigated the extraction of a broad range of acidic, neutral and basic 
drugs from plasma and urine using Bond Elut Certify columns. Prazepam was used 
as the Internal Standard and GC-FID was used for the analysis.
Their procedure used 2mL of sample (plasma), which was spiked with the 
appropriate drugs at 10 (ig/mL. This concentration was chosen for analytical 
convenience and to represent toxicologically relevant levels for most of the drugs. 
The spiked sample was then diluted with 6mL of 0.1M phosphate buffer and 
vortexed to homogenise the resultant mixture.
The column was then conditioned with 2mL Methanol and 2mL of phosphate buffer 
at a flow rate of 2mL/min. The extraction procedure began with the application of the 
diluted sample to the column at a flow rate of 1.5mL/min. lmL of deionised water 
was used as a wash to remove any interferences from the column. This amount was 
found to be sufficient to remove any interferences without affecting the drug 
recoveries.
In order to selectively elute the drugs from the column into two distinct groups, 
0.5mL of 0.01M Acetic Acid (pH3.3) was added to the column at a flow rate of
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L5mL/min. At this pH, the acidic and neutral drugs have non-polar character and are 
retained by the hydrophobic groups of the sorbent, while the basic drugs are retained 
by the cationic groups due to their ionic character. The column was then dried under 
vacuum for 4 minutes, before addition of 50|iL of Methanol with no vacuum. After a 
final drying period of 1 minute under vacuum to ensure the column contains no 
water, the drugs were selectively eluted.
The first solvent used was 4mL of acetone-chloroform (1:1) to elute the acidic and 
neutral drugs (Fraction A). The basic fraction was eluted using 2mL of 2% 
ammoniated ethyl acetate (Fraction B), at flow rates of 0.8 and 0.5 mL/min 
respectively.
After adding lOOfiL of prazepam (200|ig/mL), to each fraction and evaporating at 
40°C under nitrogen until lOOfiL remained, 1 or 2(iL of each extract was injected 
onto the GC.
For each of the solvent mixtures, the optimum conditions were investigated and for 
the acetone-chloroform mixture, 89% of each drug tested, was recovered using 30 to 
70% acetone in chloroform and so 50% was chosen. At this concentration, 
recoveries were highest using between 3 and 5 mL of the solvent mixture, and so 4 
mL was chosen for the elution of the acidic/neutral fraction.
If the ethyl acetate mixture contained more than 3% ammonia, it was found to 
contain too much water, which damaged the GC column. 2% was found to be 
adequate for the elution of the basic drugs. The time required for the preconditioning 
and extraction steps was approximately 30 minutes when 10 columns were used 
simultaneously.
The authors noted that neither fraction should be evaporated to dryness as this would 
lead to losses of the more volatile drugs, e.g. methamphetamine. The two fractions 
should not be added together as this would result in loss of benzodiazepines due to 
the alkaline conditions.
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The recoveries for the drugs ranged from 82.4 to 105.5%, with a relative standard 
deviation of less than 10%. Drugs which have a pKa close to the pH of the 
extraction system (3.3), e.g Diazepam, can be found in both fractions, A and B.
A modification of the above extraction procedure was reported by Chen et al11, for 
the analysis of whole blood using both Bond Elut Certify and Clean Screen DAU 
columns. A Hewlett-Packard 5880 gas chromatograph with a flame ionization 
detector (FID) was used for analysis. The oven was fitted with a 30m, HP-1 fused- 
silica wide-bore capillary column (0.53mm i.d, film thickness 0.88|im). The 
temperature program was as follows:
Initial temp. - 80 °C 
Initial Rate - 20°C/min. 
Rate A - 5 °C/min. 
Final time - 2 mins 
Injector temp. - 275 °C
Initial time - 2 mins. 
Final temp. - 215 °C 
Final temp. - 285 °C 
Total time - 26.75 mins. 
Detector temp. - 310 °C.
The injection port was in the splitless mode and the helium carrier gas flow rate was 
lOmL/min. The temperature program and GC conditions were also used in the 
previous report.
Several sample pretreatment methods were investigated and the method which gave 
better recoveries involved, spiking lmL of whole blood at a concentration of 2|ig/mL 
and then sonicating the sample for 15 minutes at room temperature. Next the blood 
was diluted with 6mL of 0.1M phosphate buffer (pH6.0), vortexed for 30 seconds 
and centrifuged at 2000 rpm for 15 minutes and the pellet removed. The extraction 
procedure used was that reported by Chen et al16, except the prazepam internal 
standard was at a concentration of 20(ig/mL.
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Sample pretreatment techniques are essential for the analysis of whole blood as the 
presence of red blood cells causes problems with solid-phase extraction. Direct 
application of whole blood onto an SPE column would result in the column 
becoming blocked and producing low and irreproducible recoveries. The problem 
associated with protein binding in plasma and serum, is of greater importance with 
whole blood. Sonication of the blood was needed to break up the red blood cells, in 
order to free the drugs which were bound to them, and the dilution step was utilised 
to reduce the viscosity of the sample and prevent blockage of the column.
This method (Method A), was compared to three precipitation methods which are 
commonly used for removal of proteins; zinc sulphate-methanol (Method B), 
acetonitrile (Method C), and Methanol (Method D). The recoveries from using 
Method A were significantly better than for the three precipitation methods and was 
used for blood pretreatment.
The removal of cholesterol which was retained on the column, was not possible 
without losing drugs. However, since the retention time did not interfere with the GC 
analysis of the drugs, no steps were taken to remove i t .
The recoveries from whole blood ranged from 81.2% and 102.5%, with relative 
standard deviations less than 8.2%. The reproducibility of Bond Elut Certify 
columns was also investigated by testing six different lots for the extraction of five 
different drugs. The recoveries were higher than 8 6% with a lot-to-lot relative 
standard deviation of less than 3.9%.
This extraction procedure was applied to CleanScreen DAU mixed-mode columns 
and the results were found to be comparable to those of Bond Elut Certify. The 
authors concluded that the method they had developed could be applied to other 
commercial mixed-mode bonded silica SPE columns that contain similar functional 
groups to those of Bond Elut Certify.
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The use of Gas Chromatography with a nitrogen-phosphorous detector (GC-NPD) 
has also been investigated by Chen et al22, and Zweipfenning et al60 using the same 
extraction procedure as previously reported. The only difference in the procedure 
used by Zweipfenning et al, was the use of 3mL of 2% ammoniated ethyl acetate, 
instead of 2mL.
GC-NPD was used to overcome the sensitivity limits of FID. An NPD can detect 
drugs in the ng/mL range and helps improve the detection limit of basic compounds, 
due to its enhanced sensitivity towards nitrogen-phosphorus containing compounds. 
The authors reported that, the peak height ratios of the drugs tested to prazepam were 
not reproducible when the oven temperature was programmed over a large range or 
when the temperature was increased to a higher rate. To compensate the temperature 
program was changed from that reported earlier26. The recoveries from whole blood 
were comparable to those reported using GC-FID for concentrations of 2|ig/mL and 
the sensitivity increase was indicated by the detection of basic drug concentrations of 
100 - 200 ng/mL.
2.3.3 Automation of SPE Procedure
SPE has a number of advantages over LLE outlined previously and one of these is the 
possibility of automation of the procedure.
Automation of present manual SPE methods would ideally improve reproducibility, 
give higher throughput, reduce labour costs, and extractions could be carried out after 
working hours.
Automated SPE systems available include, AASP® (Varian Sample Preparation 
Products: Harbor City, CA), ASPEC (Gilson: Middleton, WI), Millilab™ (Bedford:
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Milford, MA), Auto Spe-ed™ (Applied Separations: Allentown, PA) and Zymate™ 
(Zymark: Hopkinton, MA).
Krogh et al21, described an alternative method for the analysis of opiates in plasma 
and whole blood using the automated sequential trace enrichment of dialysate 
(ASTED) system for automated sample preparation. On-line dialysis is used as a 
purification step prior to chromatographic analysis, and with slight modifications can 
be used for the analysis of other basic drugs. Approximately 100 plasma or whole 
blood samples can be analysed in 24 hours.
Automated methods based on the extraction procedures used in manual SPE 
methods, tend to concentrate on analysis of individual or groups of related drugs and 
very few methods were reported for screening body fluids7*24.
Chen et al24, reported a semi-automated SPE procedure for screening using 
CleanScreen DAU columns using the ASPEC system. The extraction method used 
was based on the method reported by Chen et al26, and the procedure was semi­
automated, as the collection tubes had to be changed manually to collect the two 
fractions (A and B).
The recoveries ranged from 73% for methamphetamine to 96.3% for 
methylphenobarbital, with relative standard deviations of less than 5%. The 
recoveries were comparable to those acheived by manual SPE methods, and the 
reproducibilities were better.
Chen et aP, then reported an improved fully automated SPE procedure using the 
ASPEC system with Bond Elut Certify with recoveries ranging from 80% to 103%, 
with relative standard deviations less than 4.6%.
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2.4 Conclusion
Based on the available literature, the manual SPE method reported by Chen et al11, 
was selected for the purposes of this project along with GC-FID for analysis. Bond 
Elut Certify was selected to compare the extraction efficiencies to those obtained 
from the experimental mixed-mode sorbents investigated.
Since an automated SPE system was not available, the project was designed to 
develop a manual SPE method, that could be modified to the requirements of an 
automated system as part of further work.
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Chapter Three - Experimental
3.1 Materials and Reagents
All nine drugs and the Internal Standard(IS) were supplied by the Department of 
Forensic Medicine and Science from their own store. Table 4 contains the list of 
drugs and their physical/chemical properties. Stock standards were prepared by 
appropriate dilution with a (1:1) solvent mixture of methanol and ethyl acetate to 
lmg/mL. All standards were stored in the freezer below 0 °C.
All chemicals were AC. S. grade and all solvents were HPLC grade obtained from 
BDH Laboratory, England.
Columns:
Isolute® Confirm HCX, HCX-2, HCX-3 and HCX-4 mixed-mode and Isolute® 
ENV+ Solid-Phase Extraction (SPE) columns manufactured by International Sorbent 
Technology were all supplied by Crawford Scientific (Holm Street, Strathaven, 
ML10 6NB) along with Bond Elut Certify™ SPE columns and a Vac Elut box with 
10 points manufactured by Analytichem International.
The Isolute® Confirm HCX, HCX-2, HCX-3 and HCX-4 mixed-mode columns 
differ in the non-polar character of the mixed-mode sorbent and the Isolute® ENV+ 
columns consist of hypercrossed polystyrene based polymer technology which retain 
polar analytes. Bond Elut Certify™ is a bonded silica solid SPE column, and is used 
to extract acidic, neutral and basic drugs.
Solutions:
0.1M Phosphate buffer. pH 6.0(1 Litre)
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This was prepared by adding 900mL Deionised Water (D.I.) to 13.61g of KH2PO4 
(M.W 136.09). The pH was adjusted to 6.0 with potassium hydroxide while stirring. 
This was made up to 1 litre with D.I. water, then stored in the refrigerator at < 3°C 
and discarded after 30 days.
0.1M Phosphate Buffer. pH 7.4(1 litre)
This was prepared as above except the pH was adjusted to 7.4 before adding D.I 
water to a total volume of 1 litre.
1.0M Potassium Hydroxide(lOOmL)
This was prepared by adding lOOmL D.I water to 5.6g of potassium hydroxide (MW 
56.11) and then stored at room temperature up to 3 months.
0.01M Acetic Acid. pH 3.3(100mL)
This was prepared by pipetting 57.5p.L glacial acetic acid into 50mL of D.I water. 
The solution was mixed thoroughly before bringing the total volume to lOOmL with 
D.I water and was then stored at room temperature up to two months.
2% Ammonium Hydroxide in Ethyl Acetate(lOOmL)
Prepared by adding 2mL of concentrated ammonium hydroxide to 98mL of ethyl 
acetate. This solution was sonicated for 5 minutes and was prepared fresh daily.
All glassware was cleaned in detergent, washed with water, dried, silanized and 
rinsed with methanol prior to use.
Blood:
Outdated whole blood was obtained from the Scottish Blood Transfusion Service
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Table 4: Drug Information
Drug: Amitriptyline
Mol. Wt.: 277.4 
pKa: 9.4 
Log P: 3.0
Protein Binding: 91 - 97%(plasma)
/ CH3
c h c h 2c h 2n ^
c h 3
^20^23®
Drug: Cocaine
Mol. Wt.: 303.4 
pKa: 8.6  
Log P: -
Protein Binding: -
_____ / c o o c h 3
NnQ / ° ° c~ C ^
C i 7H2 i N 0 4
Drug: Codeine
Mol. Wt.: 317.4 
pKa: 8.2 
Log P: 0.6
Protein Binding: 7 - 25% (plasma)
^  ^  c 18h 21n o 3 , h 2o  
c h 3o  0 0H
Drug: Desmethyldiazepam
Mol. Wt.: 285.3 
pKa: 3.5,12.0 
Log P: -
Protein Binding: 97%(plasma) C 6H5 C 15H l l C l N 2 °
Drug: Diazepam
Mol. Wt.: 284.7 
pKa: 3.4 
Log P: 2.7
Protein Binding: 98%(plasma)
C\H3 h
c 16h 13c i n 2o
c 6h 5
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Drug: Dihydrocodeine
Mol. Wt.: 301.4 
pKa: 8.8 
Log P: -1.5 
Protein Binding: -
^  ^  ^  "^18^ 23^ ® 3
c h 3o  o 0H
Drug: Methadone
Mol. Wt.: 309.5 
pKa: 8.3 
Log P: 2.1
Protein Binding: 90%(plasma)
9p
c 2h 5c o c c h 2c h n  ( c h 3 ) 2
c 21h 27n opi
Drug: Methamphetamine
Mol. Wt.: 149.2 
pKa: 10.1 
Log P: -
Protein Binding: -
r
yP--- CH2 CHNHCHj
C i0H 15N
Drug: Prazepam
Mol. Wt.: 324.8 
pKa: 2.7 
Log P: 3.7
Protein Binding: 97%(plasma)
r
01 | C19H17ClN2° 
C6HS
Drug: Propoxyphene
Mol. Wt.: 339.5 
pKa: 6.3 
Log P: -
Protein Binding: 70 - 80%(plasma)
9 -c 2h 5c o o c c h c h 2n  ( c h 3 ) 2 
C22H29N02
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(Carluke). The blood was screened and was found to contain none of the drugs of 
interest in this project.
3.2 Instrumentation
A Hewlett-Packard 5890 series II Gas Chromatogram equipped with an FID was used 
for the screening and analysis. A 30m HP-1 fused-silica wide-bore capillary column 
(0.53mm i.d., film thickness 0.88|nm) was installed in the GC. The injection port 
was in the splitless mode and helium was used as the carrier gas at a flow rate of 
13mL/min.
The temperature program26 was as follows:
Initial temp. - 80 °C 
Initial rate - 20 °C/min. 
Rate A - 5 °C/min. 
Final time - 2 minutes 
Injector Temp. - 275 °C
Initial time - 2 minutes 
Final temp. - 215 °C 
Final temp. - 285 °C 
Total time - 26.75 mins. 
Detector Temp. - 310 °C
Data acquisition used an HP3365 Series II ChemStation.
3.3 Experimental
The following experiments were designed to find the optimum operating conditions 
for the complete separation and identification of each of the basic drugs and the 
internal standard (IS), using Gas Chromatography (GC).
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A stock standard mixture of all nine drugs and prazepam(IS) was prepared by 
dissolving weighed aliquots of each drug in a (1:1) mixture of methanol and ethyl 
acetate. The resultant solution was diluted with the solvent mixture to obtain a 
working standard solution containing each drug at an approximate concentration of 
30 [ig/ml.
3.3.1 Optimisation of GLC Drug Separation
Two different columns and two different temperature programs were used to 
investigate the optimum separation of the nine drugs.
Column 1: HP-5 fused-silica capillary column (30m x 0.32mm i.d. x 0.25|im film 
thickness, cross-linked 5% phenyl methyl silicone).
Column 2: HP-1 fused-silica wide-bore capillary column (30m x 0.53mm i.d., film 
thickness 0 .88 jJ.m).
Temperature program No.l:
Initial temp. - 120 °C 
Initial rate - 8 °C 
Final time - 5 minutes 
Detector temp. - 310 °C
Temperature program No.2:
Initial temp. - 80 °C 
Initial rate - 20 °C/min. 
Rate A - 5 °C/min. 
Final time - 2 minutes
Injector Temp. - 275 °C
Initial time - 2 minutes 
Final temp. - 300 
Injector temp. - 275 °C
Initial time - 2 minutes 
Final temp. - 215 °C 
Final temp. - 285 °C 
Total time - 26.75 mins. 
Detector Temp. - 310 °C
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Procedure:
2|iL of the working standard solution was injected onto Column 1, firstly using 
temperature program No.l, and then temperature program No.2. Column 2 was then 
fitted into the GC oven and 2|liL  of the working standard solution was injected at 
temperature program No.2.
Results and Discussion:
Figure 3.1 represents the separation of the nine drugs, using temperature program 
No.l. The numbering of the chromatogram for each drug, corresponds as follows; 
methamphetamine(l), methadone(2), amitriptyline(3), cocaine(3), Propoxyphene(3), 
codeine(4), dihydrocodeine(4), diazepam(5), desmethyldiazepam(6), prazepam(7).
It can be seen that there was co-elution between amitriptyline, cocaine and 
propoxyphene(3) and between codeine and dihydrocodeine(4).
In order to improve the separation between the drugs, the temperature program was 
changed to No.2, and the results are presented in Figure 3.2. The analysis time was 
shortened without any loss of separation, but none of the drugs coeluting at peaks (3) 
and (4) showed any sign of separating.
The next step was to use a variety of temperature programs to try to separate the two 
peaks with coeluting drugs. Rate A was increased, but this only resulted in a longer 
analysis time and no better separation. A second rate, Rate B was introduced, to try 
and separate the peaks, but did not produce any better separation.
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Figure 3.3 represents the separation of the drugs on Column 2, at temperature 
program No.2., which are the conditions used by Chen et al27. There is no greater 
separation of the drugs than that produced using column 1, however, the peak height 
and shape have improved. At this point it was assumed that improving the separation 
would be too difficult due to the close proximity of the retention indices of the 
coeluting drugs.
Conclusion
Although both Columns 1 and 2 separated the drugs to the same extent, Column 2 
gave better peak height and shape and was therefore used with the temperature 
program and conditions used by Chen et al27. Choosing these conditions also 
allowed the comparison of the results obtained from their study with the results 
obtained from this project.
The drugs were separated into three groups to allow the analysis of all nine groups.
A modification of the GC conditions used by Chen et al27 was necessary for the 
optimum separation of the drugs. The Helium carrier gas flow rate was changed to 
13mL/min. from lOmL/min to give an analysis time of 20 minutes.
Identification was possible by calculation of the Retention Indices of the drugs 
represented in Table 5.
Retention Index (RI):
In 1985, Kovats developed the retention index system for partition chromatography 
based on n-alkanes as reference substances in order to identify solutes from
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chromatograms. The RI is related to the retention time, but is more reliable and more 
useful for compatibility and reproducibility of retention data.
By definition, the RI for a normal alkane is equal to 100 times the number of Carbon 
atoms in the compound regardless of the column packing, temperature or other 
chromatographic conditions61.
Due to the linear relationship between the logarithm of the net retention times of n- 
alkanes and the number of carbon atoms in the molecules, it is possible to relate the 
retention time of the unknown compound to that of the n-alkanes eluting before and 
after it.
Calculation of Retention Indices:
A mixture of ten alkanes ( C9, C10, Cn , C12, C15, C18, C20, C22, C24, C26) was 
prepared in hexane and 2p.L of the resultant solution was injected into the GC at the 
conditions stated to produce Figure 3.4.
The retention index RI(A) of a compound A can be calculated using the following 
equation:
log[t(A) + t(X)]
RI(A) = [RI(Y) - RI(X)]________________  + RI(X) .......... (1)
log[t(Y) + t(X)]
where,
t(A) = net retention time of substance A
t(X) = net retention time of the n-alkane CxFhx+2 eluting immediately before A 
t(Y) = net retention time of the n-alkane CyH2y+2 eluting immediately after A 
RI(A), RI(X), etc. = retention index of substances A, X, etc...
Figure 3.5, represents the graphical means by which the RI of a compound can be 
determined.
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Table 5: Retention Indices
Elution Order 
of Drugs
Retention
Index61
Calculated
RI
(Eqn. 1)
Retention Time 
(mins)
M eth amphetamine 1175 1165 4.719
M ethadone 2145 2146 12.458
Cocaine 2187 2188 12.991
Propoxyphene 2190 2192 13.040
Amitriptyline 2194 2194 13.057
Codeine 2375 2390 15.688
Dihydrocodeine 2390 2390 15.822
Diazepam 2428 2417 16.049
Desm ethyldiazepam 2490 2467 16.736
3.3.2 Reproducibility of Retention times
For the purposes of identification of drugs, an assessment of the reproducibility of 
retention times(RT) is required. This was done as follows:
Procedure:
The retention times of all nine drugs and the IS were tested for within and between- 
day run variability. 2(iL of the working solutions were injected onto the GC ten 
times. The results are represented in Table 6 .
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Table 6: Reproducibility of Retention Times
Drug Within Day Runs Between Day Runs
Mean Std. Dev C.V% Mean Std. Dev. C.V%
Metham phetamine 4.719 7.4E-4 0.0156 4.720 1.8E-3 0.0376
Methadone 12.458 7.4E-4 0.0059 12.463 3.2E-3 0.0259
Amitriptyline 13.057 1.7E-4 0.0013 13.057 4.1E-3 0.0315
Codeine 15.688 9.5E-4 0.0061 15.683 2.1E-3 0.0135
Diazepam 16.049 6.7E-4 0.0042 16.048 7.2E-3 0.0450
Desmethyldiazepam 16.736 6.8E-4 0.0040 16.738 5.4E-3 0.0325
Cocaine 12.991 6.3E-4 0.0049 12.990 2.7E-3 0.0217
Propoxyphene 13.040 3.0E-4 0.0023 13.039 2.7E-3 0.0204
Dihydrocodeine 15.822 4.2E-4 0.0027 15.822 9.3E-4 0.0059
Prazepam 19.091 5.1E-4 0.0042 19.094 6.8E-3 0.0325
Results:
The results for the within-day runs shows higher reproducibility with standard 
deviations ranging from 1.7 x 10"4 to 9.5 x 10*4, with the coefficient of variance (%) 
ranging from 0.0013 to 0.0156. The between-day runs do not show as high 
reproducibility as the within-day runs, with standard deviations ranging from 9.3 x 
10'4 to 7.2 x 10'3, and the coefficient of variance (%) ranging from 0.0059 to 0.0450. 
However the use of the HP-1 column at the temperature program and conditions 
stated was found to be suitable for the separation of the basic drugs and for the 
purpose of this research.
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3.3.3 Linearity in Detector Response
Linearity in the detector response is necessary for accurate quantification. For this 
purpose and also for finding the lower limit of detection, the detector response for 
each of the drugs was investigated.
The Limit of Detection is defined as the minimum level of analyte detectable under 
the assay conditions, while the Limit of Determination is the minimum level of 
analyte which can be reliably determined. Both these factors are dependent on the 
sensitivity of the analyte and the baseline noise levels at the time of determination, 
which are also dependent on the performance of the operating system.
The parameters can be calculated as follows:
Limit of Detection = Weight which produces a response which is 
double the amplitude of the noise.
Limit of Determination = weight which produces a response which
is six times the amplitude of the noise or 
three times the Limits of Detection.
Procedure:
Serial dilutions of the stock standards were obtained to give two ranges of 
concentrations which were prepared with two different fixed amounts of internal 
standard (IS). The use of two different concentrations of IS was required to produce 
a peak height response similar to that produced by the drugs. Each concentration was 
injected (2jiL) five times. The detector response ratio can be calculated using the 
ratio of the peak height or area of the drug standard to that of the IS, but for the
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purposes of this project the peak height ratios proved to be more accurate and were 
calculated as follows:
_ _ . Peak Height of Drug StdResponse Ratio = -----------------------------------
Peak Height of IS
Results:
The two sets of calibration curves for each of the nine unextracted standards are 
presented in Appendix 1 and were constructed by plotting the equivalent 
concentration of the drug in blood, versus the response ratio. The integration results 
for these graphs are shown in Table 7, where,
Y =Ax + C,
and, y = response ratio, x = drug concentration.
Table 7 : Calibration Curve Data
Drug level A C R2
Methamphetamine ng 0.37063 -0.00719 0.99984
ng 0.00231 -0.02526 0.99958
Methadone ng 0.38905 0.01757 0.99917
ng 0.00439 -0.00607 0.99987
Amitriptyline Hg 0.72505 -0.028 0.99994
ng 0.00500 0.00139 0.99982
Codeine ng 0.23351 -0.02816 0.99992
ng 0.00074 -0.00355 0.99965
Diazepam ng 0.06024 -0.00038 0.99990
ng 0.00058 -0.00453 099926
Desmethyldiazepam ng 0.37208 -0.00285 0.99952
ng 0.00290 -0.06421 0.99953
Cocaine ng 0.40084 -0.06098 0.99959
ng 0.00221 -0.00946 0.99968
Propoxyphene ng 0.51278 -0.04939 0.99970
ng 0.00124 0.009189 0.99943
Dihydrocodeine ng 0.09959 -0.01842 0.99936
ng 0.00061 0.002777 0.99959
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The results show high linearity and reproducibility, for all the drugs at concentrations 
ranging from therapeutic levels (ng/mL) to fatal levels (pig/mL).
Table 8 , includes the theoretical limits of detection for each of the nine basic drugs 
and the limit of determination, which were determined by serial dilution of the stock 
standard solutions.
Table 8: Limits of Detection and Limits of Determination(ng/mL)
Drug Limit of Detection Limit of Determination
Meth amphetamine 7.5 22.5
Methadone <8.0 24.0
Amitriptyline <8.5 25.5
Codeine 9.0 27.0
Diazepam 16 48.0
Desmethyldiazepam 8.2 24.6
Cocaine 8.0 24.0
Propoxyphene 8.5 25.5
Dihydrocodeine 8.0 24.0
An Evaluation o f Mixed-mode Solid-Phase Extraction Columns for the Recovery of Basic Drugs from Whole Blood
Chapter Three Experimental page48
3.4 Development of Extraction Procedure
The following experiments were used to optimise the extraction procedure for 
efficient recovery of the nine drugs, using the three experimental mixed-mode SPE 
columns. The three extraction methods were carried out on all six SPE columns and 
the percentage recoveries for each drug and column combination were compared. 
The methods differed in the pH of the buffer used and the volume of the eluting 
solvent.
3.4.1 Application of Blood to SPE columns 
Procedure: Method A
Sample Preparation - 100|iL of the appropriate working standard solution was 
added to a glass vial and then diluted with lmL of outdated blood, to give 
approximate drug concentrations of 3|ig/mL. The sample was then sonicated for 15 
minutes at room temperature in a sonic bath before dilution with 6mL of 0.1M 
phosphate buffer (pH6.0). The diluted blood was vortexed for 30 seconds then 
centrifuged at 2000  rpm for 15 minutes and the pellet discarded.
Extraction procedure - The extraction was carried out on each of the six SPE 
columns, which were installed on a 10 point Vac Elut box. The nine extraction steps 
are described below and are summarised in a schematic diagram in Figure 3.6.
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Step Eight 
Concentration
IOOuL Prazepam
Step Nine 
GC Analysis
2uL
Injection Volume
Step Two ^
Sample Application
Diluted Blood 
Flow R ate = 1.5mL/min,
Step Five 
Column Drying
Dried under Vacuum, 4mins.
50uL M ethanol 
Dried under Vacuum, lmln.
Step One ^
Column Preconditioning
2mL M ethanol 
2mL P h o sphate  Buffer
Flow R ate  = 2mL/min.
Step Seven 
Elution of Neutral/Basic Drugs
2% Ammonlated Ethyl Acetate 
Flow R ate = 0.5ml_/min.
Step Four 
pH Adjustment
0.5mL, 0.01 M Acetic 
Acld(pH3.3)
Flow R ate = 1.5mL/nnin
^ Flow R ate = 1.5ml_/mir)
1 mL Deionized W ater
Step Three 
Column Wash
Step Six ^
Elution of Acidic/Neutral Drugs
4mL A cetone-C hloroform (l :1)
Flow R ate = 0.8mL/min.
Figure 3.6: Schematic Diagram of Extraction Procedure
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Step 1:
2mL of Methanol was introduced onto the column, followed by 2mL of phosphate 
buffer (pH6.0) at a flow rate of 2mL/min as a preconditioning step.
Step 2:
The blood sample was applied to the column at a flowrate of 1.5mL/min.
Step 3:
The column was then washed with lmL of deionized water at a flowrate of 
1.5mL/min.
Step 4:
The pH was adjusted by passing 0.5mL of 0.01M Acetic Acid (pH3.3) at a flowrate 
of 1.5mL/min.
Step 5:
The column was dried under a vacuum for 4 minutes before addition of 50fiL of 
methanol, followed by a further 1 minute of drying under vacuum.
Step 6:
The column outlet and manifold basin were wiped clean with a tissue before adding 
4mL of acetone-chloroform(l:l). The extract (Fraction A) was collected in a labelled 
evaporation tube at a flowrate of 0.8mL/min.
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Step 7:
2mL of 2% ammoniated ethyl acetate was drawn through the column at a rate of 
0.5mL/min and collected in a separate labelled evaporation tube (Fraction B).
Step 8:
100|iL of Prazepam (33p.g/mL) was added to each fraction, before both were 
evaporated at 40°C in a water bath under a nitrogen stream until approximately 
100 [J.L of solvent remained in each tube.
Step 9:
2fiL of each fraction was injected into the GC.
Results and Discussion:
The recoveries for the six columns using Method A are shown in Table 9 and were 
found to vary depending on the drug extracted and the column used. Each percentile 
given in the table is the mean value of three separate extractions, none having a 
Standard deviation in excess of 9.6. Columns HCX-2, HCX-3, HCX-4 and Bond 
Elut Certify(BEC) gave recoveries of greater than 60% for all of the drugs.
Addition of the internal standard to the blood sample before the extraction would 
require taking into account the extraction recovery of prazepam(IS).
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Table 9: Percentage Recoveries - Method A (pH6.0)
Drugs HCX HCX-2 HCX-3 HCX-4 ENV+ BEC
Methamphetamine 46.8 75.8 79.1 75.0 46.5 103
Methadone 89.1 84.8 88.3 86.9 82.7 83.3
Amitriptyline 79.4 60.0 71.6 75.3 57.4 76.5
Codeine 68.3 81.8 70.2 68.5 104 83.5
Diazepam 73.3 66.4 67.7 70.4 66.7 70.3
Desmethyldiazepam 72.1 68.6 70.0 70.6 63.2 71.2
Cocaine 99.5 80.4 101 105 112 90.0
Propoxyphene 84.5 93.6 91.2 83.6 88.8 89.8
Dihydrocodeine 73.0 88.4 63.5 74.2 77.3 85.4
3.4.2 Effect of pH on Recovery 
Procedure: Method B
The sample preparation and extraction procedure for Method B was the same as for 
Method A, except that the 0.1M phosphate buffer was changed from pH6.0 to 
pH7.4.
Results and Discussion:
Table 10 contains the data for both Methods A and B. Method B gave better or 
comparable results with the odd exception. Each percentile given in the table is the
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mean value of three separate extractions, none having a standard deviation in excess 
of 9.6 for Method A and 7.5 for Method B. Column HCX gave recoveries greater 
than 66.4%, and HCX-2 (> 64.2%), HCX-3 (> 62.8%) and HCX-4 (> 60.4%).
Table 10: Percentage Recoveries - Methods A and B
I Drugs HCX HCX-2 HCX-3 HCX-4 ENV+ bec lJ
M etham phetamine(A) 46.8 75.8 79.1 75.0 46.5 103
(B) 83.9 87.9 79.2 80.9 24.0 89.3
M ethadone(A) 89.1 84.8 88.3 86.9 82.7 83.3
(B) 98.4 102 84.7 60.4 68.8 77.7
Am itriptyline(A) 79.4 60.0 71.6 75.3 57.4 76.5
(B) 67.5 67.9 62.8 62.0 65.3 55.5
Codeine(A) 68.3 81.8 70.2 68.5 104 83.5
(B) 70.9 85.1 80.2 86.6 108 85.8
Diazepam (A) 73.3 66.4 67.7 70.4 66.7 70.3
(B) 74.9 69.1 74.8 62.8 72.3 75.4
Desm ethyldiazepam(A) 72.1 68.6 70.0 70.6 63.2 71.2
(B) 66.4 64.2 71.6 90.1 64.6 73.7
3.4.3 Effect of pH and Increased Solvent Volume 
Procedure: Method C
Using the 0.1M phosphate buffer (pH7.4) as in Method B, the sample preparation 
and extraction steps were the same as Methods A and B except that, 3mL of 2% 
ammoniated ethyl acetate was used to elute the basic drugs in Step 7 instead of 2mL.
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Results:
The results for Method C shown in Table 11 were very disappointing, with the 
majority of drug recoveries having decreased in comparison to Method B. As in each 
case before, the percentile given in the table is the mean value of three separate 
extractions, none having a standard deviation in excess of 9.6 for Method A, 7.5 for 
Method B and 11.4 for Method C.
Columns HCX and HCX-3 had recoveries greater than 51.2 and 50.8% respectively.
Table 11: Percentage Recoveries - Methods A, B and C
D rugs H C X H C X -2 H C X -3 H C X -4 EN V + B E C  |
M etham phetamine(A) 46.8 75.8 79.1 75.0 46.5 103
(B) 83.9 87.9 79.2 80.9 24.0 89.3
(C) 103 97.3 90.0 57.7 19.9 84.3
M ethadone(A) 89.1 84.8 88.3 86.9 82.7 83.3
(B) 98.4 102 84.7 60.4 68.8 77.7
(C) 81.1 74.7 63.1 82.1 59.5 72.1
Amitriptyline(A) 79.4 60.0 71.6 75.3 57.4 76.5
(B) 67.5 67.9 62.8 62.0 65.3 55.5
(C) 51.2 49.6 64.8 49.3 54.8 45.6
Codeine(A) 68.3 81.8 70.2 68.5 104 83.5
(B) 70.9 85.1 80.2 86.6 108 85.8
(C) 102 82.8 80.6 79.5 103 99.5
Diazepam (A) 73.3 66.4 67.7 70.4 66.7 70.3
(B) 74.9 69.1 74.8 62.8 72.3 75.4
(C) 59.9 60.5 62.2 60.5 59.1 55.7
Desm ethyldiazepam(A) 72.1 68.6 70.0 70.6 63.2 71.2
(B) 66.4 64.2 71.6 90.1 64.6 73.7
(C) 54.5 50.9 50.8 41.4 48.8 59.2
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3.4.4 Discussion and Summary of Results
The peak height ratios of each drug to that of Prazepam was used for quantitation. 
The % recoveries from whole blood shown in Tables 9, 10 and 11 were calculated by 
comparison of peak height ratios (P.H.R) of the extract with the calibration graph 
produced from drug standards.
Figures 3.7, 3.8 and 3.9 represent the extracts produced from Fractions A and B using 
phosphate buffers at pH 6.0 and 7.4 on Column HCX-3. The chromatogram produced 
using pH6.0 buffer was cleaner than that of the pH7.4 extract. However, there was 
no problem with co-extracting materials in either case.
The results shown in Table 11, show good recoveries for quantification purposes. 
Using method A, columns HCX-2, -3, -4 and BEC gave recoveries of greater than 
60% for all drugs, while Method B gave better or comparable results with the odd 
exception. Method C was excluded as a greater solvent volume was required and this 
did not improve the drug recoveries.
The standard deviations from the three extraction methods, were higher than those 
reported in the literature from similar experiments26’27. This may be due to the use of 
water flow to create the required pressure for regulating the flow through the SPE 
columns. The water pressure varied throughout the day and so it was very difficult to 
maintain the required flow rates. As a consequence of this, a greater variation in the 
recoveries was observed and this in turn contributed to the higher standard 
deviations.
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Extraction Results: pH6.0
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Extraction Results: pH7.4
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Extraction Results: pH7.4
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3.5 Establishment of Extraction Procedure
3.5.1 Introduction
It was necessary to demonstrate a linear response for the procedure to enable 
quantitative analysis for the basic drugs used from sub-therapeutic levels to fatal 
levels.
Due to time restrictions, only the HCX-3 column was used for this experiment, using 
the extraction procedure, Method B.
3.5.2 Procedure
Calibration curves were constructed for each drug by plotting the response ratio of 
the peak height of the drug/IS against their corresponding spiked concentrations in 
blood.
Standards were spiked in the range of Oqg/mL to 30|ig/mL. The blood samples were 
extracted on the HCX-3 column using Method B.
3.5.3 Results
The calibration curves for all of the drugs are presented in Appendix 2, and were 
constructed by plotting the concentration of the drug in blood, versus the response 
ratio. The graphs are all linear over the specified range. The correlation coefficients 
are presented in Table 12 and range from 0.99937 to 0.99985.
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Table 12: Correlation Coefficients for Extraction Procedure
Drug R2
Methamphetamine 0.99978
Methadone 0.99985
Amitriptyline 0.99953
Codeine 0.99978
Diazepam 0.99952
Desmethyldiazepam 0.99970
Cocaine 0.99985
Propoxyphene 0.99937
Dihydrocodeine 0.99976
These results indicate that, it is possible to extract basic drugs from HCX-3 from 
blood using method B and therefore the extraction procedure can be utilised as a 
preliminary step for further analysis.
Prazepam(IS) was included in the extraction of the sample to give a quantitative 
assay. This ensures that any loss of the drug during the extraction or analysis is 
accounted for.
Prazepam was chosen as the internal standard as it satisfied the following 
requirements;
(a) Internal standard (IS), should be resolved completely from all other peaks.
(b) IS should elute close to the peaks of interest or in the middle of the range if many 
peaks are involved.
(c) The concentration of IS should be approximately similar to the drug of interest.
(d) It should have physical and chemical properties similar to the drug of interest.
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Chapter Four: Conclusion
4.1 Aim of Study
Basic drugs are frequently encountered in society, whether in a therapeutic capacity 
or increasingly as drugs of abuse. Forsyth62, reported polydrug use amongst 
participants in the Glasgow dance scene. It was found that 70% of the group had 
used stimulants and hallucinogens (cocaine, amphetamine, psilocybin and ecstacy). 
The mean number of drugs used was 10.7, with a range of 3 - 18, with a total of 51 
discrete drugs having been used.
The nine basic drugs in this study were chosen to represent drugs commonly abused 
in Scotland and for their differing physico-chemical properties. Many different 
methods are available for the analysis of body fluids, especially for urine and plasma. 
Whole blood samples proved difficult to analyse due to interference from co- 
extracting lipids and the binding power of the blood proteins.
Solid-phase extraction (SPE) was introduced as a simpler alternative to liquid-liquid 
extraction (LLE), but whole blood tended to block the columns and prevent accurate 
and reproducible recoveries. Sample pretreatment methods such as dilution and 
sonication, overcame these difficulties and resulted in a less viscous sample which 
allowed the flow of whole blood through the SPE column.
In the present study, the extraction efficiencies of three experimental mixed-mode 
SPE columns was investigated for the recovery of basic drugs from whole blood. 
These experimental columns were then compared to three mixed-mode SPE columns
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which are routinely used in clinical and forensic laboratories. Gas Chromatography 
with a flame ionisation detector (GC-FID) was used for the analysis of the drugs in 
conjunction with retention indices.
The GC oven was fitted with an HP-1 fused silica wide-bore capillary column, which 
was found to give greater separation and resolution than the HP-5 capillary column. 
The temperature program stated by Chen et al27, was found to be sufficient with a 
slight modification to the Helium carrier gas flow rate, from lOmL/min. to 
13mL/min. The conditions used were found to be suitable for the determination of 
all nine drugs in whole blood at therapeutic levels.
In order to compare the columns, three different extraction methods were 
investigated, differing in the pH of the buffer and the volume of solvent used to 
extract the basic drugs. Using a modification of the method stated by Chen et al27, 
(Method A), involving a buffer pH of 6.0, columns HCX-2, HCX-3, HCX-4 and 
Bond Elut Certify (BEC) gave the best recoveries for all nine drugs, under these 
conditions.
When the pH of the extraction system is approximately 6.0, the weakly basic drugs 
(diazepam and desmethyldiazepam) were in their un-ionised forms and were 
absorbed by the non-polar functional groups of the mixed-mode sorbent. The basic 
drugs (methamphetamine, methadone, amitriptyline, cocaine, propoxyphene, 
dihydrocodeine and codeine) were retained by both the polar and non-polar retention 
characteristics of the column.
The pH of the extraction system was adjusted to 3.3 using 0.01M acetic acid, in order 
to selectively elute the drugs from the column. The weakly basic drugs with pKa's
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close to 3.3 were in their non-ionised form and so were eluted using 4mL of 
acetone:chloroform (1:1).
The basic drugs with pKa values higher than pH3.3 and the remaining weakly basic 
drugs were in their ionised forms and were retained on the column until, the addition 
of 2mL, 2% ammoniated ethyl acetate which firstly discharged and then eluted the 
drugs by ethyl acetate.
When the pH was changed to 7.4, (Method B), columns HCX, HCX-2, HCX-3 and 
HCX-4 gave comparable or better recoveries than Bond Elut Certify or ENV+ 
columns for each of the drugs under these conditions. Method B also gave better or 
comparable recoveries in comparison to Method A, for all six columns and each of 
the nine drugs.
Changing the pH from 6.0 to 7.4, increased the recoveries of the majority of the basic 
drugs and this is most probably a result of the increase in the number of drugs in their 
un-ionised form, which leads to a greater retention of the drugs by both the non-polar 
and polar retention characteristics of the column.
Method C involved the use of an increased elution volume, but this resulted in a 
reduction in the drug recoveries for each of the six SPE columns. One reason for this 
could be due to the loss of drugs during the increased evaporation time.
In conclusion, both methods A and B can be used to successfully extract basic drugs 
from whole blood. Both methods are simple, rapid and reproducible, ideal for routine 
analysis in a forensic laboratory.
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4.2 Future Work
In order to establish the extraction procedure for each of the columns, a linear 
response needs to be demonstrated, for the procedure, and this in turn enables 
quantitative analysis of the basic drugs. Due to time restrictions, only the HCX-3 
column was used to estalish the extraction procedure, Method B and so this 
procedure should also be carried out for each of the remaining five columns.
In addition, further studies would be of great interest, using the experimental 
columns for the extraction of body fluids other than whole blood, e.g. urine, vitreous 
humor and hair. The use of alternative detection methods would also provide 
information on the sensitivity of each method for the drugs analysed. A comparison 
between Gas Chromatography (GC) and High Performance Liquid Chromatography 
(HPLC) is one such case.
Greater optimisation of the extraction procedure for each of the columns would also 
prove beneficial and could be adapted for the analysis of other toxicologically 
relevant drugs. Improvements in recoveries could also result from the use of a better 
elution solvent, greater control of the vacuum and flow rates, and the use of different 
buffer pH's.
A more in depth analysis of the exact mechanisms at work within the experimental 
SPE columns would be advantageous for the optimisation of a mixed-mode sorbent 
which could be used to selectively extract a wide range of drugs from a variety of 
different biological fluids and this is the subject of further work currently being 
undertaken in the laboratory.
An Evaluation o f Mixed-Mode Solid-Phase Extraction Columns for the Recovery of Basic Drugs from Whole Blood
Chapter Four Conclusion page65
The analysis of blood samples from authentic cases is also necessary in order to 
evaluate the method for routine analysis.
An Evaluation of Mixed-Mode Solid-Phase Extraction Columns for the Recovery of Basic Drugs from Whole Blood
Appendix 1
Calibration Curves (18) of Unextracted Standards 
Concentration = ng/mL and (ig/mL.
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Appendix 2
Calibration Curves (9) of Basic Drugs Recovery From Blood 
Concentration = ng/mL to pg/mL.
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